Related references
Note: Only part of the references are listed.Prospects for combining targeted and conventional cancer therapy with immunotherapy
Philip Gotwals et al.
NATURE REVIEWS CANCER (2017)
Enhanced Clearance of Pseudomonas aeruginosa by Peroxisome Proliferator-Activated Receptor Gamma
Brahmchetna Bedi et al.
INFECTION AND IMMUNITY (2016)
A PGC1α-mediated transcriptional axis suppresses melanoma metastasis
Chi Luo et al.
NATURE (2016)
The metabolic co-regulator PGC1α suppresses prostate cancer metastasis
Veronica Torrano et al.
NATURE CELL BIOLOGY (2016)
Cancer immunology community seeks better end points
Elie Dolgin
NATURE REVIEWS DRUG DISCOVERY (2016)
Pioglitazone after Ischemic Stroke or Transient Ischemic Attack
W. N. Kernan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Subcellular compartmentalization of docking protein-1 contributes to progression in colorectal cancer
Teresa Friedrich et al.
EBIOMEDICINE (2016)
Treatment in vitro with PPARα and PPARγ ligands drives M1-to-M2 polarization of macrophages from T. cruzi-infected mice
Federico Penas et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2015)
Impaired efferocytosis in human chronic granulomatous disease is reversed by pioglitazone treatment
Ruby F. Fernandez-Boyanapalli et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2015)
Pioglitazone restores phagocyte mitochondrial oxidants and bactericidal capacity in chronic granulomatous disease
Ruby F. Fernandez-Boyanapalli et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2015)
Erosion of the chronic myeloid leukaemia stem cell pool by PPARγ agonists
Stephane Prost et al.
NATURE (2015)
The consensus molecular subtypes of colorectal cancer
Justin Guinney et al.
NATURE MEDICINE (2015)
Immunopathogenesis of IBD: current state of the art
Heitor S. P. de Souza et al.
Nature Reviews Gastroenterology & Hepatology (2015)
The Role of Chemokines in Shaping the Balance Between CD4+ T Cell Subsets and its Therapeutic implications in Autoimmune and Cancer Diseases
Nathan Karin et al.
FRONTIERS IN IMMUNOLOGY (2015)
Intestinal steroidogenesis controls PPAR expression in the colon and is impaired during ulcerative colitis
Guillaume Bouguen et al.
GUT (2015)
An ERK/Cdk5 axis controls the diabetogenic actions of PPARγ
Alexander S. Banks et al.
NATURE (2015)
Up-regulation of c-MYC and SIRT1 expression correlates with malignant transformation in the serrated route to colorectal cancer
Lydia Kriegl et al.
Oncotarget (2015)
Deficiency of caveolin-1 in Apcmin/+ mice promotes colorectal tumorigenesis
Teresa Friedrich et al.
CARCINOGENESIS (2013)
Compartment-specific activation of PPAR governs breast cancer tumor growth, via metabolic reprogramming and symbiosis
Paola Avena et al.
CELL CYCLE (2013)
Cell-specific PPARγ deficiency establishes anti-inflammatory and anti-fibrogenic properties for this nuclear receptor in non-parenchymal liver cells
Eva Moran-Salvador et al.
JOURNAL OF HEPATOLOGY (2013)
PPAR Activation Induces M1 Macrophage Polarization via cPLA2-COX-2 Inhibition, Activating ROS Production against Leishmania mexicana
J. A. Diaz-Gandarilla et al.
BIOMED RESEARCH INTERNATIONAL (2013)
Inhibition of PPARγ in myeloid-lineage cells induces systemic inflammation, immunosuppression, and tumorigenesis
Lingyan Wu et al.
BLOOD (2012)
Role of c-MYC in alternative activation of human macrophages and tumor-associated macrophage biology
Oscar M. Pello et al.
BLOOD (2012)
Oncogenic Kras-Induced GM-CSF Production Promotes the Development of Pancreatic Neoplasia
Yuliya Pylayeva-Gupta et al.
CANCER CELL (2012)
Role of PPARγ in COX-2 Activation in Mycobacterial Pulmonary Inflammation
Mari Kogiso et al.
INFLAMMATION (2012)
PPAR-γ is a major driver of the accumulation and phenotype of adipose tissue Treg cells
Daniela Cipolletta et al.
NATURE (2012)
Prognostic Significance of Tumor-Associated Macrophages in Solid Tumor: A Meta-Analysis of the Literature
Qiong-wen Zhang et al.
PLOS ONE (2012)
Investigating Intestinal Inflammation in DSS-induced Model of IBD
Janice J. Kim et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2012)
The role of peroxisome proliferator-activated receptors in carcinogenesis and chemoprevention
Jeffrey M. Peters et al.
NATURE REVIEWS CANCER (2012)
Activation of PPARγ in Myeloid Cells Promotes Lung Cancer Progression and Metastasis
Howard Li et al.
PLOS ONE (2011)
Transcriptional regulation of macrophage polarization: enabling diversity with identity
Toby Lawrence et al.
NATURE REVIEWS IMMUNOLOGY (2011)
The Role of T cell PPARγ in mice with experimental inflammatory bowel disease
Amir J. Guri et al.
BMC GASTROENTEROLOGY (2010)
Ink4a/Arf and Oncogene-Induced Senescence Prevent Tumor Progression during Alternative Colorectal Tumorigenesis
Moritz Bennecke et al.
CANCER CELL (2010)
PPARγ Ligands Switched High Fat Diet-Induced Macrophage M2b Polarization toward M2a Thereby Improving Intestinal Candida Elimination
Lise Lefevre et al.
PLOS ONE (2010)
Peroxisome proliferator-activated receptor gamma activation is required for maintenance of innate antimicrobial immunity in the colon
Laurent Peyrin-Biroulet et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Nuclear receptor transrepression pathways that regulate inflammation in macrophages and T cells
Christopher K. Glass et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Colorectal Cancer Expression of Peroxisome Proliferator-Activated Receptor γ (PPARG, PPARgamma) Is Associated With Good Prognosis
Shuji Ogino et al.
GASTROENTEROLOGY (2009)
The nuclear receptor PPARγ selectively inhibits Th17 differentiation in a T cell-intrinsic fashion and suppresses CNS autoimmunity
Luisa Klotz et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Deletion of PPARγ in Alveolar Macrophages Is Associated with a Th-1 Pulmonary Inflammatory Response
Anagha Malur et al.
JOURNAL OF IMMUNOLOGY (2009)
Implications for KRAS status and EGFR-targeted therapies in metastatic CRC
Nicola Normanno et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2009)
A Central Role for Foxp3+Regulatory T Cells in K-Ras-Driven Lung Tumorigenesis
Courtney A. Granville et al.
PLOS ONE (2009)
Macrophage-specific PPARγ controls alternative activation and improves insulin resistance
Justin I. Odegaard et al.
NATURE (2007)
APC inactivation associates with abnormal mitosis completion and concomitant BUB1B/MAD2L1 up-regulation
Miguel Abal et al.
GASTROENTEROLOGY (2007)
Peroxisome proliferator activated receptor γ in colonic epithelial cells protects against experimental inflammatory bowel disease
M. Adachi et al.
GUT (2006)
Peroxisome proliferator-activated receptor γ (PPAR-γ) ligands reverse CTL suppression by alternatively activated (M2) macrophages in cancer
Jo A. Van Ginderachter et al.
BLOOD (2006)
Tissue-specific and inducible Cre-mediated recombination in the gut epithelium
F El Marjou et al.
GENESIS (2004)
Adipose-specific peroxisome proliferator-activated receptor γ knockout causes insulin resistance in fat and liver but not in muscle
WM He et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Targeted expression of oncogenic K-ras in intestinal epithelium causes spontaneous tumorigenesis in mice
KP Janssen et al.
GASTROENTEROLOGY (2002)
Peroxisome proliferator-activated receptor γ-retinoid X receptor agonists increase CD36-dependent phagocytosis of Plasmodium falciparum-parasitized erythrocytes and decrease malaria-induced TNF-α secretion by monocytes/macrophages
L Serghides et al.
JOURNAL OF IMMUNOLOGY (2001)
Share Paper
